Publication | Closed Access
Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis.
38
Citations
15
References
2015
Year
The use of metformin in patients with hepatocellular carcinoma receiving radiotherapy was associated with higher overall survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1